“…This line of research yields promise, including the clinical setting, as it may lead to protocols which are easier to implement and applicable to a potentially wider class of patient populations with disorders associated with cerebrovascular dysfunction. Such disorders include arterial stenosis (Mandell et al, 2008b) and occlusion (De Vis et al, 2015), enhanced risk of stroke (Gur et al, 1996;Markus and Cullinane, 2001;Silvestrini et al, 2000), stenoocclusive diseases such as Moyamoya disease (Donahue et al, 2013;Mikulis et al, 2005), small-vessel diseases (Conklin et al, 2011(Conklin et al, , 2010 and Alzheimer's disease (Marmarelis et al, 2016(Marmarelis et al, , 2013Silvestrini et al, 2011). Beyond cerebrovascular diseases, we speculate that modeling dCVR within structures involved in central chemoreception could provide valuable insight towards understanding and treating diseases associated with respiratory control.…”